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Human cells (HEK 293, HeLa, MCF-7) and zebraﬁsh embryos were
metabolically tagged with an alkynyl myristic acid probe, lysed
with an SDS buffer and tagged proteomes ligated to multi-
functional capture reagents via copper-catalyzed alkyne azide
cycloaddition (CuAAC). This allowed for afﬁnity enrichment and
high-conﬁdence identiﬁcation, by delivering direct MS/MS evi-
dence for the modiﬁcation site, of 87 and 61 co-translationally
myristoylated proteins in human cells and zebraﬁsh, respectively.
The data have been deposited to ProteomeXchange Consortium
(Vizcaíno et al., 2014 Nat. Biotechnol., 32, 223–6) (PXD001863 and
PXD001876) and are described in detail in Multifunctional
reagents for quantitative proteome-wide analysis of protein
modiﬁcation in human cells and dynamic protein lipidation during
vertebrate development' by Broncel et al., Angew. Chem. Int. Ed.
& 2015 Published by Elsevier Inc. This is an open access article
under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).is an open access article under the CC BY license
rwa), e.tate@imperial.ac.uk (E.W. Tate).
M. Broncel et al. / Data in Brief 4 (2015) 379–383380Speciﬁcations tableSubject area Biology, chemical proteomics, post-translational modiﬁcation
More speciﬁc
subject areaProtein myristoylationType of data Proteomics, tandem mass spectrometry
How data was
acquiredMass spectrometry using a Q Exactive mass spectrometer (Thermo Fisher Scientiﬁc)Data format Raw LC–MS/MS, searched with PEAKS7 and MaxQuant 1.5
Experimental factors Samples were processed using tagging by substrate methodology
Experimental
featuresTryptic peptides were detected by LC–MS/MS and identiﬁed by database searches with two independent
proteomics platformsData source location http://proteomecentral.proteomexchange.org/cgi/GetDataset?ID=PXD001863
http://proteomecentral.proteomexchange.org/cgi/GetDataset?ID=PXD001876Data accessibility The data have been uploaded to the ProteomeXchange Consortium [1] (PXD001863 and PXD001876) and
are described in detail by Broncel et al. [2]Value of the data The largest repository for myristoylated proteins in human cells.
 First database for myristoylated proteins in zebraﬁsh.
 First quantitative description of myristoylation dynamics in a developing vertebrate.1. Experimental design
Cells and zebraﬁsh were metabolically tagged with an alkynyl myristic acid analogue or myristic
acid control. Following lysis the tagged proteins were ligated via CuAAC to multifunctional capture
reagents, [2] afﬁnity enriched and digested to peptides before LC–MS/MS analysis (Fig. 1). Generated
spectra were processed with MaxQuant [3] and PEAKS [4] software for protein identiﬁcations and
lipid modiﬁed peptide discovery, respectively. Myristoylated proteins and peptides detected in this
study have been deposited as PXD00186 (human) and PXD001876 (zebraﬁsh). Quantitative data
(triplex dimethyl labelling) [5] revealing myristoylation dynamics during zebraﬁsh development was
included as a part of repository submission PXD001876.2. Materials and methods
2.1. Cell and zebraﬁsh culture
Cells (HEK 293, HeLa, MCF-7) were maintained in DMEMþ10% FBS, at 10% CO2, and at 37 1C.
Zebraﬁsh were maintained according to standard practices. All procedures were conformed to U.K.
Home Ofﬁce regulations (ASPA 1986) under Animal Project Licence no. PPL 70/7472. Adult zebraﬁsh
strains AB were kept at 28 1C on 14 h light and 10 h dark cycle. Embryos were obtained from natural
spawnings and were maintained in system water (combination of tap and reverse osmosis water).
2.2. Metabolic tagging and lysis
Cells: the mediumwas supplemented with 20 mM YnMyr or Myr for 24 h, then washed twice with
Phosphate 10 mM Buffered pH 7.4 Saline 0.154 M (PBS) and lysed on ice using the following lysis
buffer: PBS, 0.1% SDS, 1% Triton X-100, 1 EDTA-free complete protease inhibitor. Lysates were kept
on ice for 20 min, and then centrifuged at 17,000g for 20 min and supernatants collected and stored at
80 1C. The Bio-Rad DC Protein Assay was applied to determine protein concentration.
Zebraﬁsh: embryos were placed in system water containing 0.0001% methylene blue (zebraﬁsh
water). The embryos were treated as described in Laughlin et al. [6] with minor adjustments. At 4–5 h
post-fertilization (hpf), 48 hpf and 96 hpf the embryos were dechorionated with pronase (1 mg/mL,
Fig. 1. Schematic overview of the experimental design used in this study. For details of visualisation of enriched proteomes see [2].
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most of the chorions. The embryos were transferred into 1% agarose-coated wells of a 48-well plate
containing 250 μL of zebraﬁsh water supplemented with 20 mM YnMyr or 20 mM Myr and incubated
for 24 h before they were euthanized with MS-222 solution (250 mg/L). The embryos were transferred
to 1.5 ml Eppendorf tubes and deyolked using a protocol described in Link et al. [7] and further treated
as described in Hinz et al. [8] with adjustments. The embryos were washed with 200 μL ice-cold lysis
buffer: PBS, 2 EDTA-free complete protease inhibitor. The solution was removed and replaced by
fresh lysis buffer (100 μL). Zebraﬁsh embryos were homogenised with a Kimbles Kontes Disposable
pellet pestle with cordless motor. SDS (1%) and Benzonases Nuclease (0.5%) were added and the
lysates were vortex-mixed at RT for 5 min and heated at 95 1C for 10 min. Lysates were allowed to cool
down on ice for 5 min, diluted with lysis buffer to 250 μL and supplemented with Triton X-100 (0.2%).
Lysates were centrifuged (16,000g) at 4 1C for 10 min, supernatants collected and used for further
experiments or stored at 80 1C.
2.3. CuAAC and sample preparation for MS-based proteomics
Cells: 0.4 mg (small scale) or 2 mg (large scale) of proteins at the concentration of 2 mg/mL was
incubated with a premixed solution of a capture reagent (0.1 mM), CuSO4 (1 mM), TCEP (1 mM) and TBTA
(0.1 mM). The samples were vortex-mixed at RT for 1 h before the addition of EDTA (10 mM), methanol (4
v/v), chloroform (1 v/v), and water (3 v/v). The samples were vortex-mixed brieﬂy, centrifuged (10,000g)
at RT for 20 min to produce protein pellets, which were reconstituted in 1% SDS in PBS at 2 mg/mL, and
the precipitation step was repeated. Following centrifugation, the pellets were washed with methanol and
brieﬂy dried on air. The pellets were reconstituted in 2% SDS in PBS at 5 mg/mL, and PBS was added to
dilute the samples to 1 mg/mL. Bioorthogonally labelled proteins were enriched on prewashed
NeutrAvidin agarose resin (50 mL slurry/1 mg of lysate) for 2 h at RT. Following the removal of
supernatants the beads were washed with 1% SDS in PBS (3 ), 4 M urea in 50 mM AMBIC (2 ) and
50 mM AMBIC (5 ). The beads were treated with 5 mM DTT for 30 min at 55 1C, and then with 10 mM
iodoacetamide for 30 min at RT, in the dark. The beads were washed with 50 mM AMBIC twice after each
step. Protein digestion was initiated upon addition of trypsin or chymotrypsin, 1/1000 w/w protease to
pre-pull-down protein, and samples were incubated overnight at 37 1C or 25 1C, respectively. The samples
were brieﬂy centrifuged, diluted 1:1 with 0.1% TFA, and stage-tipped according to a published protocol. [9]
Peptides were eluted from the sorbent (SDB-XC, from 3M) with 70% acetonitrile in water, followed by
SpeedVac-assisted solvent removal, reconstitution in 0.5% TFA, 2% acetonitrile in water, and transfer into
LC–MS sample vials. All samples were prepared in triplicates.
Zebraﬁsh: samples were processed as described for cell-based experiments with adjustments. For
label free experiments, CuAAC reaction was carried out with 1.5 mg of proteins (mix of 30.5 mg2
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experiments, CuAAC reaction was carried out with 0.2 mg of proteins. Triplex dimethyl labelling
was performed according to a published protocol, [5] and the samples (24 h pulse tagging ending at
24, 72 and 120 hpf) were mixed 1:1:1 prior to the SpeedVac-assisted solvent removal. All experiments
involved biological triplicates.
2.4. LC–MS/MS analysis
The analysis was performed using an Acclaim PepMap RSLC column 50 cm75 μm inner diameter
(Thermo Fisher Scientiﬁc) using a 2 h acetonitrile gradient in 0.1% aqueous formic acid at a ﬂow rate of
250 nL/min. Easy nLC-1000 was coupled to a Q Exactive mass spectrometer via an easy-spray source
(all Thermo Fisher Scientiﬁc). The Q Exactive was operated in data-dependent mode with survey scans
acquired at a resolution of 75,000 at m/z 200 (transient time 256 ms). Up to 10 of the most abundant
isotope patterns with charge þ2 or higher from the survey scan were selected with an isolation
window of 3.0 m/z and fragmented by HCD with normalised collision energies of 25. The maximum
ion injection times for the survey scan and the MS/MS scans (acquired with a resolution of 17,500 at
m/z 200) were 20 and 120 ms, respectively. The ion target value for MS was set to 106 and for MS/MS
to 105, and the intensity threshold was set to 8.3102.
2.5. Proteomics data analysis with MaxQuant
The data were processed with MaxQuant [3] (version 1.5.0.25) and the peptides were identiﬁed
from the MS/MS spectra searched against human complete proteome (Uniprot, September 2014) [10]
using Andromeda [11] search engine. Cysteine carbamidomethylation was selected as a ﬁxed
modiﬁcation and methionine oxidation as a variable modiﬁcation, the minimum peptide length was
set to 7 amino acids. Myristoylated peptide search was performed applying the following variable
peptide N-terminal modiﬁcations that corresponded to the added masses of alkynyl myristic acid
ligated to multifunctional capture reagents: þ463.2907; þ633.4326; þ406.2692; þ520.3373;
þ624.3999, [2] the minimum peptide length was reduced to 6 amino acids. For in silico digests of the
reference proteome the following peptide bond cleavages were allowed: arginine or lysine followed
by any amino acid (trypsin); phenylalanine, tyrosine or tryptophan followed by any amino acid
(chymotrypsin). Up to two missed cleavages were allowed. The false discovery rate was set to 0.01 for
peptides, proteins and sites. Other parameters were used as pre-set in the software. “Unique and razor
peptides” mode was selected to allow identiﬁcation and quantiﬁcation of proteins in groups. Label-
free quantiﬁcation (LFQ) was performed using a built-in algorithm enabling the ‘Match between runs’
option (time window 0.7 min). The experiment comprised three replicates treated with YnMyr (and
three replicates treated with Myr, where applicable). Triplex dimethyl labelling experiments in
MaxQuant were performed using the built-in quantiﬁcation algorithm enabling the ‘Match between
runs’ (time window 0.7 min) and ‘Re-quantify’ features. Light (þ0 Da), medium (þ4 Da) and heavy
(þ8 Da) intensities were selected for a triplex experiment.
2.6. Proteomics data analysis with PEAKS suite
The data for modiﬁed peptide discovery were processed with PEAKS7, [4] which as a default
performs de novo peptide sequencing prior to database searches, in order to improve the accuracy of
the results. The software also searches for common PTMs (PEAKS PTM) and point mutations (SPIDER).
Samples originating from cell lines and zebraﬁsh experiments were searched against the same
reference Uniprot [10] Homo sapiens and Danio rerio databases that were used in MaxQuant analyses.
Trypsin (speciﬁc, up to three missed cleavages allowed) was selected for database searches, and no
enzyme was chosen in de novo searches (up to 5 candidates per spectrum reported). The maximal
mass error was set to 5 ppm for precursor ions and 0.01 Da for product ions. Carbamidomethylation
was selected as a ﬁxed modiﬁcation, and methionine oxidation as well as the lipid-derived adduct
(þ463.2907 Da) to any amino acid at peptide N-terminus were set as variable modiﬁcations. The
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for peptides and minimum of 1 unique peptide per protein was required. For N-terminally
myristoylated peptides, b1 ions were required.Acknowledgements
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